<DOC>
	<DOCNO>NCT00437658</DOCNO>
	<brief_summary>This study design see research compound ( NBI-56418 ) work compare DMPA-SC ( also know depo-provera ) woman endometriosis see may affect bone mineral density .</brief_summary>
	<brief_title>Safety Efficacy Study NBI-56418 Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<criteria>Be female , age 18 49 year , inclusive Have moderate severe pelvic pain due endometriosis Have surgically ( laparoscopy laparotomy ) diagnose endometriosis within last 7 year recurrent persistent endometriosis symptom Have regular menstrual cycle ( 2333 day ) Agree use two form nonhormonal contraception study Are currently receive GnRH agonist , GnRH antagonist , DMPASC DMPAIM receive agent within last 12 month Are currently use hormonal contraception form hormonal therapy receive treatment within last month Have surgery endometriosis within last month Are currently smoke 20 cigarette per week Are use systemic steroid chronic regular basis within 3 month Have uterine fibroid pelvic lesion â‰¥5 cm diameter Have pelvic pain cause endometriosis Have unstable medical condition chronic disease Have pregnant within last year currently breast feed</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>